Avanos Medical, Inc.AVNSNYSE
Loading
EBITDA Margin Over TimeContracting
Percentile Rank21
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Percentile
P21
Within normal range
vs 3Y Ago
-0.4x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2025-4.73%+90.6%
2024-50.25%-768.6%
20237.52%-33.9%
202211.37%+73.2%
20216.57%+2447.1%
2020-0.28%+83.9%
2019-1.73%-130.6%
20185.67%+5881.9%
2017-0.10%+99.2%
2016-11.57%-